These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34197114)

  • 1. Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework.
    Durek T; Kaas Q; White AM; Weidmann J; Fuaad AA; Cheneval O; Schroeder CI; de Veer SJ; Dellsén A; Österlund T; Larsson N; Knerr L; Bauer U; Plowright AT; Craik DJ
    J Med Chem; 2021 Jul; 64(14):9906-9915. PubMed ID: 34197114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.
    Durek T; Cromm PM; White AM; Schroeder CI; Kaas Q; Weidmann J; Ahmad Fuaad A; Cheneval O; Harvey PJ; Daly NL; Zhou Y; Dellsén A; Österlund T; Larsson N; Knerr L; Bauer U; Kessler H; Cai M; Hruby VJ; Plowright AT; Craik DJ
    J Med Chem; 2018 Apr; 61(8):3674-3684. PubMed ID: 29605997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
    Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.
    Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ
    J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.
    Mayorov AV; Cai M; Chandler KB; Petrov RR; Van Scoy AR; Yu Z; Tanaka DK; Trivedi D; Hruby VJ
    J Med Chem; 2006 Mar; 49(6):1946-52. PubMed ID: 16539382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists.
    Grieco P; Cai M; Liu L; Mayorov A; Chandler K; Trivedi D; Lin G; Campiglia P; Novellino E; Hruby VJ
    J Med Chem; 2008 May; 51(9):2701-7. PubMed ID: 18412316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.
    Cai M; Marelli UK; Bao J; Beck JG; Opperer F; Rechenmacher F; McLeod KR; Zingsheim MR; Doedens L; Kessler H; Hruby VJ
    J Med Chem; 2015 Aug; 58(16):6359-67. PubMed ID: 26218460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists.
    White AM; Dellsén A; Larsson N; Kaas Q; Jansen F; Plowright AT; Knerr L; Durek T; Craik DJ
    J Med Chem; 2022 Oct; 65(19):12956-12969. PubMed ID: 36167503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive pharmacophore model of human melanocortin-4 receptor as derived from the solution structures of cyclic peptides.
    Sun H; Greeley DN; Chu XJ; Cheung A; Danho W; Swistok J; Wang Y; Zhao C; Chen L; Fry DC
    Bioorg Med Chem; 2004 May; 12(10):2671-7. PubMed ID: 15110848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic analogs of alpha-melanocyte-stimulating hormone (alphaMSH) with high agonist potency and selectivity at human melanocortin receptor 1b.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    Peptides; 2008 Jun; 29(6):1010-7. PubMed ID: 18378043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant agouti-signaling protein on melanocortin action.
    Yang YK; Ollmann MM; Wilson BD; Dickinson C; Yamada T; Barsh GS; Gantz I
    Mol Endocrinol; 1997 Mar; 11(3):274-80. PubMed ID: 9058374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Cai M; Han G; Trivedi D; Campiglia P; Novellino E; Hruby VJ
    Peptides; 2007 Jun; 28(6):1191-6. PubMed ID: 17482720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of cyclic peptide penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2) at the human melanocortin-1 and -4 receptors: His(6) substitution.
    Cheung AW; Danho W; Swistok J; Qi L; Kurylko G; Rowan K; Yeon M; Franco L; Chu XJ; Chen L; Yagaloff K
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1307-11. PubMed ID: 12657270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
    de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
    Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.
    Chu XJ; Bartkovitz D; Danho W; Swistok J; Cheung AW; Kurylko G; Rowan K; Yeon M; Franco L; Qi L; Chen L; Yagaloff K
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4910-4. PubMed ID: 16169218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
    Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
    Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.